INBP · Integrated Biopharma Inc
Market Cap
$5.59M
Shares
31.06M
INBP metrics
67 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.18
Market cap
$5.59M
Price action
19 metricsPrice change (1W)
+3.4%
Price change (30D)
+20.0%
Price change (3M)
-5.3%
Price change (6M)
-40.0%
Price change (YTD)
-50.0%
Price change (1Y)
-30.8%
Trailing year
Price change (5Y)
-81.1%
52-week high
$0.38
52-week low
$0.15
Change from 52-week high
-52.6%
Change from 52-week low
+20.0%
Annualized volatility
75.2%
Beta
-0.5
RSI (14D)
52.1
Price vs SMA 50
+1.5%
Price vs SMA 200
-33.3%
Avg volume (3M)
8,351
Relative volume
1.2
Average dollar volume
$1,426
Company
3 metricsSector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
31.06M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 863.1%
P / book
0.3
reciprocal yield 339.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
1.8
reciprocal yield 54.1%
Earnings yield
-29.6%
Historical valuation
8 metricsP / E historical average (3Y)
10.7×
reciprocal yield 9.4%
P / E historical average (5Y)
7.0×
reciprocal yield 14.3%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 325.0%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 296.5%
EV / EBIT historical average (3Y)
25.4×
reciprocal yield 3.9%
EV / EBIT historical average (5Y)
21.7×
reciprocal yield 4.6%
EV / EBITDA historical average (3Y)
6.5×
reciprocal yield 15.4%
EV / EBITDA historical average (5Y)
6.5×
reciprocal yield 15.4%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
4.6%
Operating margin
-2.6%
Trailing 12 months
Net margin
-3.4%
Gross profit (TTM)
$2.24M
Operating profit (TTM)
−$1.25M
Net income (TTM)
−$1.65M
Trailing 12 months
Diluted EPS (TTM)
$-0.07
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-27.5%
Year over year
Net income growth YoY
-237.0%
Revenue (TTM)
$48.25M
Trailing 12 months
EPS growth YoY
-250.0%
Shares change YoY
-1.4%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.1%
Revenue CAGR (5Y)
+0.6%
EPS CAGR (3Y)
-37.0%
EPS CAGR (5Y)
-25.4%
FCF CAGR (3Y)
-19.6%
FCF CAGR (5Y)
+10.7%
Quality
14 metricsReturn on equity
-8.7%
Return on assets
-6.2%
Debt / equity
—
Current ratio
3.3
EBITDA (TTM)
−$953,000
Free cash flow (TTM)
—
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$5.83M
Total assets
$26.67M
Total debt
$18,000
Cash flow & spend
7 metricsOperating cash flow (TTM)
$3.03M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
$3.49M
Stock compensation (TTM)
$185,000
R&D / revenue
—
Stock compensation / revenue
0.4%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—